Iomazenil hyperfixation in single photon emission computed tomography study of malformations of cortical development

Norimichi Higurashi1, Shin-ichiro Hamano, Tomotaka Oritsu

  • 1Division of Neurology, Saitama Children's Medical Center, Japan. higijh.n@gmail.com

Insights

Malformations of cortical development can cause early-onset epilepsy. (123)I-iomazenil SPECT imaging in infants revealed hyperfixation in dysplastic lesions, suggesting immature neurons and GABAergic involvement in infant epilepsy.

Area of Science:

  • Neuroscience
  • Developmental Neuroscience
  • Epileptology

Background:

  • Malformations of cortical development (MCD) are a significant cause of early-onset epilepsy in infants.
  • Understanding the underlying mechanisms of epileptogenesis in MCD is crucial for effective treatment.

Observation:

  • Two cases of infants with MCD and early-onset epilepsy are presented.
  • Case 1: Left hemimegalencephaly with focal epilepsy and cluster spasms, followed by contralateral seizure origin post-hemispherectomy.
  • Case 2: Lissencephaly due to a doublecortin gene mutation, presenting with West syndrome.

Findings:

  • Both patients showed significant hyperfixation in dysplastic lesions on (123)I-iomazenil single photon emission computed tomography (SPECT) during infancy.
  • This hyperfixation suggests neuronal immaturity within the dysplastic areas.
  • Findings indicate a potential role of gamma-aminobutyric acid (GABA)ergic system dysfunction in infant epilepsy associated with MCD.

Implications:

  • Infant (123)I-iomazenil SPECT may aid in identifying epileptogenic zones in MCD.
  • Results highlight the importance of neuronal immaturity and GABAergic involvement in the pathogenesis of epilepsy in infants with MCD.
  • Further research into GABAergic modulation could offer novel therapeutic strategies for these challenging epilepsies.

Related Concept Videos